Stock RASP ACTAVIA LIFE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Market Closed - OTC Markets
Other stock markets
 03:06:58 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.009 USD -25.00% Intraday chart for Actavia Life Sciences, Inc. 0.00% +16.88%
May. 20 Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Feb. 16 Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ACTAVIA LIFE SCIENCES, INC. Stock Actavia Life Sciences, Inc.
 6.95M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. RASP Stock
  4. Charts Actavia Life Sciences, Inc.
  5. Sector Chart